secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001818382-24-000102
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte holds 2024 annual meeting; re-elects six directors and ratifies PwC as auditor
--------------------------------------------------------------------------------

- John P. Bamforth, Emery N. Brown, Michael T. Constantino, Keith Anthony Jones, Laura E. Niklason, Susan Windham-Bannister elected as Class III directors.
- Bamforth and Jones resigned and were immediately reappointed as Class II directors to rebalance board to four directors per class.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for FY2024: 69,075,479 for, 883,816 against, 72,146 abstain.
- Quorum achieved with 70,031,441 shares (58.8% of outstanding) present.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000181838224000102/0001818382-24-000102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000181838224000102/huma-20240611.htm
  HTML page:      https://secwatch.observer/filing/0001818382-24-000102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer